✦ LIBER ✦

Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): Amulticenter, open-label, non-randomized, phase III clinical trial

✍ Scribed by Yadav, Sangeeta; Manglani, M. V.; Ashwath Narayan, D. H.; Sharma, S.; Ravish, H. S.; Arora, Rohit; Bosch Castells, V.; Arya, S.; Oster, P.

Book ID: 126608396
Publisher: Indian Academy of Pediatrics
Year: 2014
Tongue: English
Weight: 483 KB
Volume: 51
Category: Article
ISSN: 0019-6061
DOI: 10.1007/s13312-014-0435-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of the recombi

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

✍ Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Immunogenicity and safety of a new menin

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial

✍ Siddhivinayak Hirve; Ashish Bavdekar; Anand Pandit; Sanjay Juvekar; Malini Patil 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Safety of a quadrivalent meningococcal s

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants

✍ Abdelnour, Arturo; Silas, Peter E.; Lamas, Marta Raquel Valdés; Aragón, Carlos F 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 623 KB